Sanofi Considers Buying US Biotech Insmed, Bloomberg Says
Sanofi is reportedly weighing a takeover of US drugmaker Insmed, according to Bloomberg News, which cites sources close to the situation.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
France's Sanofi is considering a purchase of US pharmaceutical company Insmed, Bloomberg News reported on Thursday. The report relies on people with knowledge of the situation.
No deal has been confirmed, and no terms of a possible transaction have been disclosed.
why it matters
Reports of possible takeovers typically draw investor attention to the target company's shares. If a deal went ahead, it could affect Sanofi's drug portfolio and balance sheet, but for now the matter appears to be at an early stage.
market impact
Insmed shares: reported takeover interest from Sanofi may support the stock
- Insmed shares pressure up — possible takeover interest typically supports a target's share price
tags
instruments
sources
- Sanofi Weighs Takeover Of US Drugmaker Insmed — Bloomberg News, 19 November 2026 at 15:12 UTC
- Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports — Reuters, 19 November 2026 at 15:17 UTC
- Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports — Reuters, 19 November 2026 at 15:25 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗